Shopping Cart
- Remove All
- Your shopping cart is currently empty
Benufutamab (GEN1029) is an agonistic antibody targeting death receptor 5 (DR5) with anti-tumor activity, used in the study of solid tumors.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $328 | In Stock | |
5 mg | $993 | In Stock | |
10 mg | $1,590 | In Stock | |
25 mg | $2,360 | In Stock | |
50 mg | $3,180 | In Stock |
Description | Benufutamab (GEN1029) is an agonistic antibody targeting death receptor 5 (DR5) with anti-tumor activity, used in the study of solid tumors. |
In vitro | Benufutamab (20 μg/mL, 24h) induced cytotoxicity in primary multiple myeloma (MM) cells with a median cell killing rate of 36%. [1] |
In vivo | The antitumor activity of Benufutamab (0.5 mg/ kg-10 mg/kg, intravenously administered once a week) was confirmed in models of colorectal, pancreatic, gastric, NSCLC, and melanoma cell lines, showing significant antitumor activity. |
Alias | Hx-DR5-05, Hx-DR5-01, GEN1029, GEN 1029 |
Cas No. | 2109730-69-8 |
Storage | store at low temperature | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.